Board and Management Changes
Released
Released
Announcement PDF
Sign-up and log into ADN’s Investor Hub
Board & Management Changes
Andromeda Metals Limited (ASX: ADN) (Andromeda, the Company) is pleased to announce the
appointment of Dr Stephen Grocott as a Non-Executive Director, as part of a refresh of the Company’s
Board and management capabilities to support its current strategic priorities.
This appointment strengthens the Company’s minerals processing, technology development and battery
materials expertise as Andromeda advances its HPA opportunity, while continuing to progress opportunities
to unlock value from the Great White Project (GWP).
As part of this transition, Mr Michael (Mick) Wilkes will retire from the Board following the upcoming Annual
General Meeting and Mr Joseph Ranford will transition from his full-time executive role to a consulting
arrangement. This structure retains access to Mr Ranford’s project knowledge and experience while
aligning the Company’s ongoing cost base and resourcing with its current activities.
Dr Stephen Grocott – appointment as Non-Executive Director
Dr Stephen Grocott will be appointed to the Board of Andromeda as a Non-Executive Director, effective
immediately following the upcoming Annual General Meeting on the remuneration set out at the end of
this announcement.
Dr Grocott brings more than 40 years’ experience across minerals processing, technology development,
commissioning, operations technical support, environment, intellectual property and mergers &
acquisitions/due diligence functions in the international minerals processing industry.
He is an accomplished executive in the mining and mineral processing sector, most recently as Group
Head, Processing and Closure at Newmont Corporation. Prior to this, he was Non-Executive Director at
Queensland Pacific Metals, where he previously was Managing Director & CEO and responsible for its
project to produce battery chemicals and high-purity alumina. He also has senior management
experience with Sunrise Energy Metals, Rio Tinto, BHP and Alcoa. Dr Grocott brings particularly relevant
expertise in process and technology development, together with exposure to electric vehicle (EV) and
battery producers and a world-class expertise in process and project development for minerals processing
and battery chemicals.
Dr Grocott’s appointment strengthens the Board’s technical and commercial capability as Andromeda
progresses its HPA strategy and considers pathways to unlock value from the Great White Project.
Andromeda Metals Limited ASX: ADN
ASX Announcement
10/431 King William Street
Adelaide, SA 5000
Tel:+61 8 7089 9800
ir@andromet.com.au
30 October 2026
ABN
75 061 503 375
Andromeda Metals Limited | 2
Mr Michael (Mick) Wilkes – retirement as a Non-Executive Director
As part of the Board transition, Mr Michael (Mick) Wilkes has elected to retire as a Non-Executive Director
at the conclusion of the upcoming Annual General Meeting.
Mr Wilkes joined the Board as Chair in April 2022 and served in that role until September 2024, when he
stepped down as Chair and continued as a Non-Executive Director.
The Board thanks Mick for his significant contribution, guidance and commitment during his tenure.
Mr Joseph Ranford – transition to Consultant
The Company advises that, by mutual agreement, Mr Joseph Ranford will transition from his full-time
executive role as Chief Operating Officer to a consulting arrangement for a 6 month period,
effective 30 October 2026.
The transition will reduce the Company’s ongoing corporate cost base while retaining Mr Ranford’s
experience and knowledge as required.
The Company thanks Mr Ranford for his contribution as Chief Operating Officer and his committed role in
advancing the Company’s Great White and HPA projects.
Andromeda’s Executive Chair, Sue-Ann Higgins said:
“The Company warmly welcomes Stephen to the Board. His extensive experience across industrial
minerals, technology development, HPA and electric vehicle (EV) and battery supply chain is a valuable
addition to the Board, and highly relevant to Andromeda as we advance our HPA opportunity and
continue to pursue pathways to unlock value from the Great White Project.
“Stephen’s appointment brings complementary technical and commercial expertise to the Board at an
important time for the Company.
“The Board also thanks Mick for the significant contribution he has made as Chair and Non-Executive
Director during his time with the Company. "
“We also thank Joe for his considerable contribution as Chief Operating Officer. We are pleased that his
experience and detailed knowledge of our projects will remain available to the Company through his
consulting role as we align our resourcing with our current priorities.”
This announcement has been approved for release by the Board of Andromeda Metals Limited.
For more information about the Company and its projects, please visit our website,
www.andromet.com.au or contact:
Investor Relations
1800 161 380 (within Australia)
+61 8 7089 9819 (from outside Australia)
E: ir@andromet.com.au
Andromeda Metals Limited | 3
Fees payable to Dr Grocott
Dr Grocott will receive annual Non-Executive Director fees of $116,000, consistent with the Company’s
existing Non-Executive Directors. For the period from his appointment to 31 December 2026, these fees will
be satisfied through zero exercise price options, subject to Shareholder approval, calculated at $0.00672
per option, consistent with the basis applied to the service fee options offered to the Company’s other
Non-Executive Directors for that period.
In addition to his role as a Non-Executive Director, Dr Grocott will separately provide consulting services to
the Company, where required, for work outside the scope of his director duties at a rate of $380 per hour
(inclusive of GST).
About Andromeda
Andromeda Metals (ASX: ADN) is an Australian company focused on delivering the next generation of superior-quality
industrial and critical minerals.
Through advancing the development of our portfolio of high-quality kaolin resources and processing technologies, we
are seeking to supply superior-quality industrial and critical minerals into established and emerging global markets.
Andromeda’s primary focus is on advancing our Great White Project (GWP) towards a final investment decision, while
also pursuing the commercialisation of our proprietary process to produce High Purity Alumina (HPA) from kaolin
feedstock.
Andromeda HPA Project represents a significant opportunity to create a new critical minerals business alongside the
GWP and is founded on more than eight years of research and development focused on processing refined Great
White kaolin into HPA products using our patented processing technology. The project aims to establish a cost-
competitive supply of HPA for rapidly growing global technology markets.
HPA is a critical material used in batteries, semiconductors, LEDs, synthetic sapphire and advanced ceramics. The
Company's strategy is to create long-term shareholder value through the development of premium industrial mineral
products and advanced materials markets.
Share your feedback
Discover